JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.28% |
| 2 | Healthcare | 12.84% |
| 3 | Financials | 10.61% |
| 4 | Consumer Discretionary | 7.72% |
| 5 | Industrials | 7.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3551
Matthews International
MATW
$725M
| $1.61M | ﹤0.01% |
52,803
-8,481
| -14% | -$237K |
|
3552
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.78B
| $1.6M | ﹤0.01% |
32,222
+2,939
| +10% | +$145K |
|
|
CNCE
3553
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $1.6M | ﹤0.01% |
274,282
+186,915
| +214% | +$983K |
|
3554
ARK Web x.0 ETF
ARKW
$1.8B
| $1.6M | ﹤0.01% |
41,469
+4,820
| +13% | +$211K |
|
3555
Opko Health
OPK
$1.03B
| $1.6M | ﹤0.01% |
1,278,818
-1,095,358
| -46% | -$1.73M |
|
3556
Tootsie Roll Industries
TR
$3.08B
| $1.6M | ﹤0.01% |
42,254
+4,506
| +12% | +$164K |
|
|
AMWD
3557
DELISTED
American Woodmark
AMWD
| $1.6M | ﹤0.01% |
32,668
-2,073
| -6% | -$103K |
|
3558
Mitek Systems
MITK
$877M
| $1.59M | ﹤0.01% |
163,841
+25,522
| +18% | +$269K |
|
3559
MeiraGTx Holdings
MGTX
$1.3B
| $1.59M | ﹤0.01% |
243,509
-4,460
| -2% | -$30.6K |
|
3560
ePlus
PLUS
$2.31B
| $1.58M | ﹤0.01% |
35,807
-10,917
| -23% | -$509K |
|
3561
MacroGenics
MGNX
$269M
| $1.58M | ﹤0.01% |
236,097
-93,359
| -28% | -$512K |
|
3562
CALL
Northrop Grumman
NOC
$83.2B
| $1.58M | ﹤0.01% |
2,900
+2,700
| +1,350% | +$1.41M |
|
|
VRAY
3563
DELISTED
ViewRay, Inc.
VRAY
| $1.58M | ﹤0.01% |
352,592
-123,612
| -26% | -$538K |
|
3564
ANI Pharmaceuticals
ANIP
$1.76B
| $1.57M | ﹤0.01% |
39,112
+3,545
| +10% | +$133K |
|
3565
CALL
Revvity
RVTY
$13B
| $1.57M | ﹤0.01% |
+11,200
| New | +$1.51M |
|
3566
CALL
Flex
FLEX
$46.6B
| $1.57M | ﹤0.01% |
96,871
+47,772
| +97% | +$717K |
|
3567
AAR Corp
AIR
$5.85B
| $1.56M | ﹤0.01% |
34,853
-76,316
| -69% | -$3.32M |
|
3568
Nuveen ESG Small-Cap ETF
NUSC
$1.35B
| $1.56M | ﹤0.01% |
45,764
+6,683
| +17% | +$233K |
|
3569
Enerpac Tool Group
EPAC
$1.89B
| $1.56M | ﹤0.01% |
61,445
-2,629
| -4% | -$63.4K |
|
|
AILE
3570
DELISTED
iLearningEngines, Inc. Common Stock
AILE
| $1.56M | ﹤0.01% |
+155,000
| New | +$1.54M |
|
|
GOGN
3571
DELISTED
GoGreen Investments Corporation
GOGN
| $1.56M | ﹤0.01% |
+150,000
| New | +$1.54M |
|
3572
PUT
Legend Biotech
LEGN
$3.95B
| $1.55M | ﹤0.01% |
31,100
-10,900
| -26% | -$528K |
|
3573
AMERISAFE
AMSF
$513M
| $1.55M | ﹤0.01% |
29,866
-4,806
| -14% | -$254K |
|
3574
Pediatrix Medical
MD
$2.16B
| $1.55M | ﹤0.01% |
104,365
+6,819
| +7% | +$111K |
|
|
DAWN
3575
DELISTED
Day One Biopharmaceuticals
DAWN
| $1.55M | ﹤0.01% |
72,006
-5,308
| -7% | -$109K |
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,940 increased, 2,285 reduced and 594 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 594 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.